ViroPharma is currently conducting two Phase 2 dose ranging studies of oral maribavir at one of three doses in transplant recipients.
http://www.biospace.com/news_story.aspx?StoryID=301356&full=1
http://www.biospace.com/news_story.aspx?StoryID=301356&full=1
No comments:
Post a Comment